Unexpected pleural effusions in 3 pediatric patients treated with STI-571

J Pediatr Hematol Oncol. 2002 Nov;24(8):694-5. doi: 10.1097/00043426-200211000-00020.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Benzamides
  • Bone Marrow Transplantation
  • Camptothecin / administration & dosage
  • Camptothecin / analogs & derivatives*
  • Child
  • Combined Modality Therapy
  • Edema / etiology
  • Enzyme Inhibitors / adverse effects*
  • Etoposide / therapeutic use
  • Female
  • Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Imatinib Mesylate
  • Irinotecan
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
  • Leukemic Infiltration / drug therapy
  • Lung Neoplasms / secondary
  • Lung Neoplasms / therapy
  • Male
  • Neoplasm Proteins / antagonists & inhibitors
  • Neuroectodermal Tumors, Primitive / secondary
  • Neuroectodermal Tumors, Primitive / therapy
  • Piperazines / adverse effects*
  • Pleural Effusion / chemically induced*
  • Proto-Oncogene Proteins c-kit / drug effects
  • Pyrimidines / adverse effects*
  • Remission Induction
  • Sarcoma, Ewing / secondary
  • Sarcoma, Ewing / therapy
  • Testis / pathology
  • Topotecan / administration & dosage

Substances

  • Antineoplastic Agents
  • Benzamides
  • Enzyme Inhibitors
  • Neoplasm Proteins
  • Piperazines
  • Pyrimidines
  • Etoposide
  • Irinotecan
  • Topotecan
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Imatinib Mesylate
  • Proto-Oncogene Proteins c-kit
  • Camptothecin